Bharat Rasayan Limited (BHARATRAS)
₹997.50 +1.24% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Bharat Rasayan's revenue was ₹338 Cr (-10.4% year on year, +9.8% on the previous quarter), and net profit ₹37.2 Cr (-6.1% year on year); the operating margin was 15.0%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹338 | -10.4% | +9.8% |
| Operating profit | ₹50.8 | -30.6% | +3.6% |
| Net profit | ₹37.2 | -6.1% | -2.0% |
| EPS (₹) | 22.40 | -6.1% | -2.4% |
| Operating margin | 15.0% | — | — |
EPS restated for the ₹10 to ₹5 split of Dec 2025 and the 1:1 bonus of Dec 2025: Q1 FY26 ₹95.45 to ₹23.86.
BHARATRAS delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 53.38% of the BHARATRAS shares traded on NSE were taken to delivery, against the stock's own 20-session average of 52.97%. That is close to its usual level. Turnover was only ₹41 lakh, so a handful of trades can move this figure. Volume was 0.2 times its average, well below normal.
Delivery in the last 5 sessions: 55.7% · 41.2% · 50.1% · 53.1% · 53.4%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Bharat Rasayan Limited conducted its 37th Annual General Meeting on September 24, 2026, transacting 12 resolutions covering ordinary and special business. Shareholders approved the FY26 financial statements and a final dividend of ₹0.50 per equity share. The meeting also voted on key related-party transactions with B R Agrotech, Bharat Certis AgriScience, and JV partner Nissan Bharat Rasayan. Additionally, auditor notes confirmed sub judice environmental damage compensation of ₹14.78 crore deposited under protest regarding the 2022 Dahej fire incident.
- 37th AGM held on September 24, 2026, transacting 12 total ordinary and special resolutions
- Final dividend of ₹0.50 per equity share approved for the financial year ended March 31, 2026
- Material related-party transactions approved with B R Agrotech, Bharat Certis AgriScience, and JV Nissan Bharat Rasayan
- Disclosed sub judice Environmental Damage Compensation of ₹14.78 crore deposited under protest before the Supreme Court
Bharat Rasayan Limited has informed exchanges regarding the closure of its trading window for dealing in company securities with effect from October 1, 2026. The closure complies with SEBI (Prohibition of Insider Trading) Regulations and pertains to the quarter ending September 30, 2026. The window will reopen 48 hours after the declaration of the un-audited financial results. The date of the Board Meeting to approve these results will be notified in due course.
- Trading window closes with effect from October 1, 2026
- Closure is for the quarter ending September 30, 2026
- Window to remain closed until 48 hours after the declaration of un-audited financial results
- Board meeting date to approve results will be intimated in due course
Promoter Mahabir Prasad Gupta transferred 11,59,673 equity shares (6.98% stake) of Bharat Rasayan Limited to MPG Family Trust via an off-market gift with nil consideration. The transfer was executed on August 24, 2026, under an exemption granted by SEBI Order dated June 12, 2026. Following the transaction, Mahabir Prasad Gupta's direct holding decreased from 9.97% to 2.99%, while MPG Family Trust holds 6.98%. The acquisition is an internal family arrangement for succession planning and does not alter the overall promoter group holding.
- MPG Family Trust acquired 11,59,673 equity shares (6.98% of total share capital) via off-market gift.
- Transferor Mahabir Prasad Gupta's direct holding reduced from 16,56,676 shares (9.97%) to 4,97,003 shares (2.99%).
- Transaction executed under SEBI Exemption Order No. WTM/KCV/CFD/03/2026-27 dated June 12, 2026.
- Total voting capital of the company stands at 1,66,21,072 equity shares of face value Rs 5 each.
Promoter Mahabir Prasad Gupta has transferred 11,59,673 equity shares (6.9771% stake) of Bharat Rasayan Limited to the MPG Family Trust via an off-market gift with nil consideration. The transaction is an internal private family arrangement for succession planning and asset consolidation. The transfer was carried out pursuant to an exemption from open offer obligations granted by SEBI vide order dated June 12, 2026.
- Acquisition of 11,59,673 equity shares representing a 6.9771% stake in the company
- Off-market transfer executed via gift with NIL consideration
- Exemption from SEBI SAST Regulations 3(1) and 4 granted under order dated June 12, 2026
- Prior disclosure under Regulation 10(5) was filed with the stock exchange on 17-08-2026
Bharat Rasayan Limited announced that MPG Family Trust, part of the promoter group, acquired 11,59,673 equity shares (6.9771%) via an off-market transfer by way of gift at nil value. The transaction is a private family arrangement for succession planning and internal promoter reorganization, executed pursuant to an exemption granted by SEBI vide order dated June 12, 2026. Total promoter holding (74.99%) and public shareholding remain unchanged, with zero change in management control or business operations.
- 11,59,673 equity shares (6.9771% of equity) transferred to MPG Family Trust
- Off-market transfer executed as a gift with NIL monetary consideration
- Carried out under SEBI Exemption Order No. WTM/KCV/CFD/03/2026-27 dated June 12, 2026
- No change in aggregate promoter group shareholding or management control
Bharat Rasayan Limited disclosed a SEBI exemption order regarding the proposed transfer of shares to the MPG Family Trust, settled by promoter Mahabir Prasad Gupta. The company has a total paid-up capital of INR 8.31 crore across 1,66,21,072 shares of INR 5 each. As of March 2026, the promoter group holds a 74.99% stake (1,24,64,240 shares), including Mahabir Prasad Gupta's 9.97% holding (16,56,676 shares). The transaction is an internal estate planning restructuring with no change in overall promoter holding or public shareholding.
- Promoter group holds 74.99% (1,24,64,240 shares) and public shareholding stands at 25.01% (41,56,832 shares)
- Trustee Mahabir Prasad Gupta holds 16,56,676 equity shares representing 9.97% of total voting capital
- Company's paid-up share capital is INR 8,31,05,360 divided into 1,66,21,072 equity shares of INR 5 each
- Exemption application was filed on April 09, 2026 seeking relief from open offer obligations under SAST Regulations
Bharat Rasayan reported a 10.4% YoY decline in Q1 FY27 revenue to ₹338.16 cr, with Net Profit dropping 16% to ₹36.64 cr compared to the same period last year. The Board has fixed September 17, 2026, as the record date for a final dividend of ₹0.50 per share (10% of face value). A significant strategic update includes the in-principle approval for a corporate restructuring involving BRL Finlease and Centum Finance to rationalize business verticals. The company's JV with Nissan Chemical contributed a modest ₹0.59 cr to the consolidated profit on a revenue of ₹58.49 cr.
- Q1 Revenue from operations stood at ₹338.16 cr, a decrease from ₹377.40 cr in the year-ago quarter.
- Net Profit for the quarter declined to ₹36.64 cr from ₹43.66 cr in Q1 FY26.
- Final dividend of ₹0.50 per equity share (10% of ₹5 face value) announced with Record Date of Sept 17, 2026.
- In-principle approval granted for restructuring involving BRL Finlease Limited and Centum Finance Limited.
- Joint Venture Nissan Bharat Rasayan reported a profit after tax of ₹1.97 cr for the quarter.
Bharat Rasayan reported a weak Q1 FY27 with revenue declining 10.4% YoY to ₹338.16 cr. Net profit fell 16.1% YoY to ₹36.64 cr, primarily driven by a contraction in operating margins from 18.69% to 14.91%. The Board has in-principally approved a corporate restructuring involving BRL Finlease and Centum Finance to rationalize business verticals. Additionally, a final dividend of ₹0.50 per share was recommended with a record date of September 17, 2026.
- Revenue from operations decreased 10.4% YoY to ₹338.16 cr from ₹377.40 cr.
- Net profit for the quarter stood at ₹36.64 cr, down from ₹43.66 cr in the previous year's quarter.
- Operating margin contracted significantly to 14.91% compared to 18.69% in Q1 FY26.
- Board approved a restructuring plan involving BRL Finlease Limited and Centum Finance Limited.
- Final dividend of ₹0.50 per share (10% of face value) recommended for FY26.
Bharat Rasayan reported a 10.4% YoY decline in standalone revenue to ₹338.16 cr for Q1 FY27, down from ₹377.40 cr in Q1 FY26. Net profit (PAT) decreased by 16.1% YoY to ₹36.64 cr, while operating margins contracted significantly to 14.91% from 18.69% a year ago. The Board has in-principally approved a restructuring plan involving its finance subsidiaries to rationalise the corporate structure. A final dividend of ₹0.50 per share (10% of face value) was also declared for FY26.
- Standalone Revenue from operations declined 10.4% YoY to ₹338.16 cr in Q1 FY27.
- Net Profit (PAT) fell 16.1% YoY to ₹36.64 cr compared to ₹43.66 cr in the same quarter last year.
- Operating Margin contracted by 378 basis points to 14.91% from 18.69% YoY.
- Board approved a restructuring involving BRL Finlease Limited and Centum Finance Limited to improve capital efficiency.
- Final dividend of ₹0.50 per share (10%) announced with a record date of September 17, 2026.
Bharat Rasayan reported a weak Q1 FY27 with revenue from operations declining 10.4% YoY to ₹338.16 Cr. Net profit (PAT) fell 16.1% YoY to ₹36.64 Cr, impacted by margin compression as operating margins dropped to 14.91% from 18.69% in the year-ago period. Alongside results, the board approved an in-principle restructuring involving BRL Finlease and Centum Finance to rationalize the corporate structure. A final dividend of ₹0.50 per share (10%) was confirmed with a record date of September 17, 2026.
- Revenue from operations fell 10.4% YoY to ₹338.16 Cr compared to ₹377.40 Cr in June 2025.
- Net Profit (PAT) declined 16.1% YoY to ₹36.64 Cr from ₹43.66 Cr.
- Operating margin contracted significantly to 14.91% from 18.69% in the same quarter last year.
- Board approved in-principle restructuring of finance-related subsidiaries BRL Finlease and Centum Finance.
- Joint Venture Nissan Bharat Rasayan contributed a small profit share of ₹0.59 Cr on revenue of ₹58.49 Cr.
Bharat Rasayan Limited has appointed Shri Varun Dabriwal as an Additional Independent & Non-Executive Director effective July 4, 2026. The appointment is for a five-year tenure concluding on July 3, 2031, subject to shareholder approval at the next Annual General Meeting. Mr. Dabriwal brings approximately 20 years of experience in business administration and corporate strategy to the board of this Rs 940 Cr market cap company. This is a routine governance update and does not impact the company's financial operations directly.
- Appointment of Shri Varun Dabriwal effective from July 4, 2026
- Fixed tenure of 5 years ending on July 3, 2031
- Appointee brings approximately 20 years of experience in corporate strategy and market development
- Company maintains a low P/E ratio of 6.5 and a debt-free balance sheet (Rs 1 Cr debt)
Bharat Rasayan Limited has submitted its quarterly compliance certificate for the period ended June 2026, as required under SEBI (Prohibition of Insider Trading) Regulations. The company confirmed that its Structured Digital Database (SDD) is fully operational and non-tamperable, with an audit trail maintained for 8 years. During the quarter, the company identified and captured 3 specific events involving Unpublished Price Sensitive Information (UPSI). No non-compliances were reported, indicating adherence to standard corporate governance protocols regarding information security.
- 3 UPSI events were identified and captured during the quarter ended June 2026
- The Structured Digital Database (SDD) is maintained internally with an audit trail capability of 8 years
- Zero non-compliances were reported for the previous quarter
- The company confirmed 100% capture of required events as per Regulations 3(5) and 3(6)
Shri Naman Jain has resigned as a Non-Executive Independent Director of Bharat Rasayan Limited, effective July 01, 2026. The resignation stems from the non-fulfillment of eligibility requirements under the Companies Act, 2013, specifically the failure to clear the mandatory online proficiency self-assessment test within the required timeline. The company, which has a market capitalization of Rs 936 Cr and TTM revenue of Rs 1,242 Cr, confirmed there are no other material reasons for this departure. This is a procedural exit and is not expected to impact the company's operational or financial performance.
- Cessation of Shri Naman Jain as Independent Director effective July 01, 2026
- Resignation triggered by non-completion of the online proficiency self-assessment test per Companies Act, 2013
- Company confirms no other material reasons for the resignation in the letter dated June 30, 2026
- Bharat Rasayan maintains a strong promoter holding of 74.99% as of March 2026
Bharat Rasayan Limited has announced the closure of its trading window for all designated persons and their immediate relatives starting July 1, 2026. This move is a standard regulatory requirement under SEBI Insider Trading regulations ahead of the declaration of financial results. The window will remain closed until 48 hours after the un-audited financial results for the quarter ending June 30, 2026, are made public. The specific date for the board meeting to approve these results is yet to be announced.
- Trading window closure effective from July 1, 2026
- Closure is for the quarter ending June 30, 2026, financial results
- Window to reopen 48 hours after the official result declaration
- Complies with SEBI (Prohibition of Insider Trading) Regulations, 2015
Bharat Rasayan Limited has approved its audited financial results for the quarter and fiscal year ended March 31, 2026, reporting an unmodified audit opinion. The Board has recommended a final dividend of ₹0.50 per equity share (10% of face value), pending shareholder approval. Significant management changes include the resignation of Whole Time Director Mahabir Prasad Gupta due to health and the appointment of Vikas Gupta as an Additional Director. The company also confirmed it has no outstanding defaults on loans or debt securities as of the year-end.
- Recommended a final dividend of ₹0.50 per share (10%) on equity shares of ₹5 face value for FY 2025-26.
- Whole Time Director Mahabir Prasad Gupta resigned effective May 27, 2026, citing health reasons.
- Vikas Gupta, part of the promoter group with a 4.58% individual stake, appointed as Additional Director effective July 1, 2026.
- Statutory auditors B.K. Goel & Associates issued an unmodified opinion on standalone and consolidated financials.
- Confirmed zero defaults on loans and debt securities as of March 31, 2026.
Financial Performance
Revenue Growth by Segment
Standalone revenue from operations reached INR 663.36 Cr for the six months ended September 30, 2025, representing a growth of 8.73% compared to INR 610.07 Cr in the previous year's corresponding period. While specific segment percentages are not disclosed, the company identifies seeds and nutrients as its high-growth segments driving future profitability.
Geographic Revenue Split
Export sales constituted 36.13% of total sales in FY2023-24, a significant decrease from 55.98% in FY2022-23. Domestic sales account for the remaining 63.87%. The company maintains 123 international registrations to support its global footprint.
Profitability Margins
Net Profit Margin for H1 FY2025-26 stood at 10.64%, a slight decline from 10.97% in H1 FY2024-25. Standalone Net Profit for H1 FY2025-26 was INR 69.82 Cr, up 4.29% from INR 66.95 Cr YoY.
EBITDA Margin
Operating Margin (PBILDT) was 14.44% for H1 FY2025-26, compared to 15.22% in H1 FY2024-25. The company's total expenses decreased by 10.97% from INR 1041.62 Cr in FY2022-23 to INR 927.36 Cr in FY2023-24, primarily due to optimized material consumption costs.
Capital Expenditure
Capital Work-in-Progress was reported at INR 2.02 Cr as of September 30, 2025. The company maintains a low gearing of 0.08x, providing significant headroom to raise debt for future capacity expansion and capex needs.
Credit Rating & Borrowing
The company holds a strong credit profile with a Debt-Equity Ratio of 0.08x as of September 30, 2025. CARE Ratings previously assigned CARE A1+ to its commercial paper (later withdrawn as unutilized). Interest Service Coverage Ratio remains robust at 37.35x for H1 FY2025-26.
Operational Drivers
Raw Materials
Technical grade pesticides and chemical intermediates. Cost of materials consumed for H1 FY2025-26 was INR 441.89 Cr, representing 66.61% of total revenue from operations.
Import Sources
Approximately 58-60% of total raw material purchases are imported. China is the primary source, accounting for 85% of total imports, followed by Japan at 12-14%.
Key Suppliers
Key suppliers include Nissan Chemical Corporation through the 30:70 Joint Venture (Nissan Bharat Rasayan Private Limited) and various vendors in China and Japan.
Capacity Expansion
Current manufacturing focuses on technical grade pesticides and formulations. While specific MTPA figures are not disclosed, the company is leveraging its JV with Nissan Chemical Corporation to enhance technical capabilities and product range.
Raw Material Costs
Raw material costs increased by 10.86% YoY to INR 441.89 Cr in H1 FY2025-26 from INR 398.61 Cr. The company utilizes a natural hedge through export sales to mitigate the impact of import cost fluctuations.
Manufacturing Efficiency
The company focuses on high-growth segments like seeds and nutrients to improve overall plant utilization and profitability.
Logistics & Distribution
Distribution costs are managed as part of 'Other Expenses' which represent approximately 10.5% of total revenue.
Strategic Growth
Expected Growth Rate
15%
Growth Strategy
Growth will be achieved through the expansion of the product portfolio in the seeds and nutrients segments, leveraging the 30:70 JV with Nissan Chemical Corporation for advanced technicals, and increasing market penetration in the 123 international markets where it holds registrations.
Products & Services
Technical grade pesticides, pesticide formulations, high-growth seeds, and plant nutrients.
Brand Portfolio
Bharat Rasayan, Nissan Bharat Rasayan (JV), B R Agrotech, and Bharat Certis Agriscience (associate).
New Products/Services
The company is entering new segments in seeds and nutrients, which are expected to be high-growth drivers for future revenue and profitability.
Market Expansion
Expansion is targeted through increasing international registrations (currently 123) and deepening the domestic reach for formulations and nutrients.
Market Share & Ranking
The company is a significant player in the Indian technical grade pesticide market and is mandated to have a Risk Management Committee as one of the top 1000 listed entities by market capitalization.
Strategic Alliances
Nissan Bharat Rasayan Private Limited is a critical 30:70 Joint Venture between Bharat Rasayan and Nissan Chemical Corporation, contributing INR 1.72 Cr in share of profit for Q2 FY2025-26.
External Factors
Industry Trends
The Indian chemical industry is seeing a shift toward domestic manufacturing of technicals to reduce import dependency. The industry is growing, but faces increasing environmental scrutiny and molecule-specific regulations.
Competitive Landscape
Competes with both domestic agrochemical players and multinational corporations in the technicals and formulations segments.
Competitive Moat
The company's moat is built on its extensive registration portfolio (584 total) and its strategic JV with Nissan Chemical, which provides access to proprietary technology. These are sustainable due to the high regulatory barriers to entry in the agrochemical space.
Macro Economic Sensitivity
Highly sensitive to agricultural output and monsoon patterns in India, as well as global commodity price cycles for agrochemicals.
Consumer Behavior
Increasing farmer preference for high-yield seeds and specialized nutrients is driving the company's shift toward these segments.
Geopolitical Risks
Significant exposure to China (85% of imports) makes the company vulnerable to trade barriers or supply disruptions originating from Chinese regulatory shifts.
Regulatory & Governance
Industry Regulations
Operations are subject to the Insecticides Act and Central Insecticides Board & Registration Committee (CIB&RC) norms. Prohibited usage of certain molecules represents a recurring regulatory risk.
Environmental Compliance
The company faces ongoing compliance requirements related to chemical manufacturing and waste disposal, though specific ESG spend figures are not disclosed.
Taxation Policy Impact
The company's effective tax rate is approximately 24.5%, with a tax expense of INR 22.66 Cr against a profit before tax of INR 92.48 Cr for H1 FY2025-26.
Legal Contingencies
The company has not disclosed any material pending court cases or litigation that would significantly impact its financial position in the provided documents.
Risk Analysis
Key Uncertainties
Fluctuations in global agrochemical prices and the potential for sudden regulatory bans on key pesticide molecules could impact margins by 10-15%.
Geographic Concentration Risk
High geographic concentration in imports (85% from China) and a shift in revenue concentration toward the domestic Indian market (63.87%).
Third Party Dependencies
Significant dependency on Chinese suppliers for raw materials and Nissan Chemical Corporation for JV-related technical expertise.
Technology Obsolescence Risk
Risk of products becoming obsolete due to the introduction of newer, more environmentally friendly molecules or biological alternatives.
Credit & Counterparty Risk
Debtors Turnover Ratio of 2.91x suggests a working capital intensive cycle, though the company maintains strong liquidity with unutilized bank lines.